North America
The North America Gigantism Drugs Market is one of the largest, driven by a high prevalence of hormonal disorders, advanced healthcare infrastructure, and a strong focus on rare disease treatment. The United States leads the region, with significant investments in healthcare and a higher awareness of gigantism. Increasing R&D in endocrinology treatments and...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian